A PDF of the Editors' conflict of interest disclosure information is available for download here.
Member, Board of Directors: Varian Biopharma
Consulting: Samus Therapeutics, Partner Therapeutics, Ascentage, Oncology Analytics
Honoraria: Pfizer
Consulting or Advisory Role: UnitedHealthcare
Research Funding: Novartis
Honoraria: Pfizer, Genentech/Roche
Speakers' Bureau: Pfizer
No conflicts to report
Honoraria: Prime Oncology, Elsevier, Itamar Medical
Consulting or Advisory Role: Monteris Medical, Incyte, AstraZeneca, Bristol-Myers Squibb, Abbvie
Research Funding: Novartis, TRACON Pharma, Novocure, Spectrum Pharmaceuticals, Lilly/ImClone, Boehringer Ingelheim
Honoraria: AstraZeneca, Eisai, Genentech/Roche, Ipsen, Puma, and Seattle Genetics
Consulting/Advisory: AstraZeneca, Eisai, Genentech/Roche, Ipsen, Puma Biotechnology, and Seattle Genetics
Institutional Research Funding: G1-Therapeutics, Lilly, Merck, Nektar, Puma Biotechnology, Seattle Genetics, and Tesaro
Intellectual Property: Jones and Bartlett and UptoDate.com
Travel, Accommodations, or other Expenses: Eisai
No conflicts to report
Consulting or Advisory Role: INC Research and Cyt RX, Marathon Pharma, Morphotek
No conflicts to report
No conflicts to report
No conflicts to report
No conflicts to report
Employment: Flatiron Health
Patents, Royalties, & Other Intellectual Property: Patents pending relating to inventions as employee of NCCN
Other Relationships: National Comprehensive Cancer Network
No conflicts to report
Employment: Texas Oncology, University of Texas Southwestern Medical Center - Simmons Cancer
Leadership: Texas Oncology, Parkland Health System
Stock & Other Ownership Interests: Amgen, Medfusion, Merck, Pfizer
Research Funding: US Oncology
Other Relationships: Mary Crowley Research Center (Dallas, Texas), American Society of Clinical Oncology, Methodist Health System (Dallas, Texas)
No conflicts to report
Leadership: Blueprint Medicines
Stock & Other Ownership Interests: Blueprint Medicines, G1 Therapeutics, Bessor Pharma, Caris Life Sciences, Champions Oncology, N-of-One
Consulting or Advisory Role: Bayer, Pfizer, Novartis, Lilly, EMD Serono, Sanofi, Janssen Oncology, PharmaMar, Daiichi Sankyo, Blueprint Medicines, Kolltan Pharmaceuticals, WIRB-Copernicus Group, ZIOPHARM Oncology, Polaris, Nektar, Genocea Biosciences, G1 Therapeutics, Caris Life Sciences, Adaptimmune, Eisai, Kyocera
Research Funding: Abbvie, Janssen Oncology
Patents, Royalties, & Other Intellectual Property: Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber and Novartis
Consulting/Advisory: Array BioPharma, Bayer Schering Pharma, Foundation of Medicine, and Natera
Consulting or Advisory Role: AMAG Pharmaceuticals, ARIAD, Biodesix, Boehringer Ingelheim, Eisai, Gilead Sciences, Helsinn Therapeutics, Lilly, Roche/Genentech
Research Funding: Puma Biotechnology
No conflicts to report
Consulting or Advisory Role: ARIAD, Takeda, AbbVie/Stemcentrx, Pfizer
Research Funding: Takeda
Research Funding (to the institution): Janssen Biotech, Novartis, Apexigen, Merck, Bristol-Myers Squibb, Astex Pharmaceuticals, Newlink Genetics, Amgen, Pfizer
Travel, Accommodations, Expenses: Genentech/Roche
No conflicts to report
No conflicts to report
Consulting/Advisory: Adaptive Biotechnologies, CStone Pharmaceuticals, Dragonfly Therapeutics, Genocea Biosciences, and Incyte
Research Funding: Aduro Biotech, Amgen, Bristol-Myers Squibb, and Corvus Pharmaceuticals;
Intellectual Property: GVAX (and has received yearly milestone payments for it)
Travel, Accommodations, or Other Expenses: Bristol-Myers Squibb, Genocea Biosciences, and MedImmune
Other Relationships: Dragonfly Therapeutics
Honoraria: CMP Healthcare Oncology Publishing, The ASCO Post
Consulting or Advisory Role: CommGeniX, International Genetics, AlphaSights
Travel, Accommodations, Expenses: Hospital Association of PA, Bristol-Myers Squibb
Other Relationships: BP
Research Funding: Pfizer, Amgen, Bristol-Myers Squibb, Novartis
Consulting or Advisory Role: Boehringer Ingelheim, Foamix, Novartis, Novocure, Quintiles, AstraZeneca, Legacy Healthcare, Janssen Research & Development, Adgero Bio Pharmaceuticals
Research Funding: Berg Pharma, Bristol-Myers Squibb
No conflicts to report
Leadership: Cellworks, LifeLink
Consulting or Advisory Role: Integra
Consulting or Advisory Role: Magellan Health
Consulting/Advisory Board: AstraZeneca
Advisory Board: Novocure, Guardant Health, Takeda
Honoraria: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene
Consulting or Advisory Role: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene
Speakers' Bureau: Genentech/Roche, Amgen, Bayer/Onyx
Research Funding: Bayer/Onyx, Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, MedImmune
Honoraria: Advaxis
Consulting or Advisory Role: Merck, NextCure, and Novartis
Research Funding: Fujifilm, Immunogen, Leap Therapeutics, Merck, Mersana, Novartis, SQZ Biotechnologies, Syndax, and Tesaro
Travel, Accommodations, Other Expenses: AstraZeneca
No conflicts to report
Consulting or Advisory Role: AbbVie, Aduro, Association of Community Cancer Centers, bioTheranostics, Boston Biomedical, Bristol-Myers Squibb, Eli Lilly, Foundation Medicine, Genentech, Genomic Health, Heron, Novartis, Taiho
No conflicts to report
Consulting or Advisory Role: Boehringer Ingelheim
Research Funding: Boehringer Ingelheim, AstraZeneca, Exelixis, Novartis, MedImmune, Merck, Genentech/Roche, Lilly, Bayer
Consulting or Advisory Role: Gerson Lehrman Group, Caris Life Sciences
Stock & Other Ownership Interests: AuraSense LLC, Nanosphere Inc.
Honoraria: Celgene, Pharmacyclics, Janssen Biotech, Valeant Pharmaceuticals International
Consulting or Advisory Role: Celgene, Genetech Health Practices Consulting, Seattle Genetics
Research Funding: Celgene, Lilly
Research Funding: Eisai, Pfizer
Institutional Research Funding: AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Genentech/Roche, Lilly, Merck, and Pfizer
Honoraria: Pfizer, Amgen, Bristol-Myers Squibb, Tesaro
Consulting or Advisory Role: Amgen, Bristol-Myers Squibb, Pfizer, Helsinn Therapeutics
Speakers' Bureau: Genentech/Roche
Research Funding: Helsinn Therapeutics
Honoraria: Genomic Health, Eisai, Genentech/Roche, Celgene
Consulting or Advisory Role: Genentech/Roche, Pfizer, Celgene, Eisai
Speakers' Bureau: Genomic Health, Eisai, Genentech/Roche, Celgene
Research Funding: Bayer
Travel, Accommodations, Expenses: Genomic Health, Genentech/Roche, Eisai, Celgene
Consulting or Advisory Role: 3M, BlueCross and BlueShield of Michigan, Amgen
Employment: UpToDate
Patents, Royalties, & Other Intellectual Property: UpToDate, Royalties from Oxford Textbook of Cancer Communication, co-editor
Travel, Accommodations, Expenses: GEOMC, Inc. Seoul, Korea
No conflicts to report as of 7/13/18
No conflicts to report
Stock & Other Ownership Interests: GlaxoSmithKline, Novartis, Teva, Medtronic, Biogen, Bristol-Myers Squibb, Celgene, Pfizer, Immunogen, Isis Pharmaceuticals, Johnson & Johnson, Merck, United Health Group, Vertex, UCAN
Research Funding: Merck
Patents, Royalties, & Other Intellectual Property: Jones and Bartlett Publisher
No conflicts to report
Consulting or Advisory Role: Genomic Health
Travel, Accommodations, Expenses: TEVA, Tel Aviv
Research Funding: Astellas Pharma, Chimerix, and Merck
Consulting or Advisory Role: Merck, Pfizer
Honoraria: Bayer, Bristol-Myers Squibb, Fresenius Kabi, Roche, Pfizer
Consulting or Advisory Role: Bayer, Pfizer
Speakers' Bureau: Bayer, Daiichi Sankyo
Travel, Accommodations, Expenses: Pfizer
No conflicts to report
Honoraria: Roche, Novartis, Pfizer, MSD Oncology, Lilly
Research Funding: Roche
Travel, Accommodations, Expenses: Celgene, MSD Oncology, Roche, Novartis
Leadership: IBA - Ion Beam Applications
Consulting or Advisory Role: IBA
Travel, Accommodations, Expenses: IBA
Consulting or Advisory Role: AstraZeneca, Amgen, Boehringer Ingelheim
Speakers' Bureau: Roche
No conflicts to report
Consulting or Advisory Role: Bristol-Myers Squibb, AstraZeneca, MSD Oncology
Speakers' Bureau: MSD Oncology, Bristol-Myers Squibb
Travel, Accommodations, Expenses: Bristol-Myers Squibb, Pfizer